Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Minority Interest (2024 - 2025)

Coeptis Therapeutics Holdings has reported Minority Interest over the past 2 years, most recently at $506163.0 for Q4 2025.

  • Quarterly results put Minority Interest at $506163.0 for Q4 2025, up 4.34% from a year ago — trailing twelve months through Dec 2025 was $506163.0 (up 4.34% YoY), and the annual figure for FY2025 was $506163.0, up 4.34%.
  • Minority Interest for Q4 2025 was $506163.0 at Coeptis Therapeutics Holdings, down from $551195.0 in the prior quarter.
  • Over the last five years, Minority Interest for COEPW hit a ceiling of $984300.0 in Q1 2025 and a floor of $132494.0 in Q2 2024.